Skip to main content
Premium Trial:

Request an Annual Quote

Genomatix Joins Illumina-Connect Program

NEW YORK (GenomeWeb News) – Genomatix Software said today that it has joined the Illumina-Connect program, an Illumina initiative to work with hardware and software firms to develop new tools and applications for genomic data generated by Illumina's platforms.

Munich, Germany-based Genomatix sells the Genomatic Mining Station and Genomatix Genome Analyzer for analyzing next-generation sequencing data.

"Working with Illumina-generated NGS data has helped us greatly in our ongoing effort to refine and further expand our analysis capabilities in this very demanding market," said Peter Grant, CEO of Genomatix Software's US operations in Ann Arbor, Mich. "Being a part of the Illumina-Connect program should help us to better focus those efforts as well as help us keep up with the rapidly expanding portfolio of Illumina NGS applications."

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.